Here are four takeaways:
1. Washington University School of Medicine researchers participated in clinical trials for new SCS devices, which deliver higher frequencies and cut down on tingling sensations.
2. Michael Bottros, MD, Barnes-Jewish Hospital assistant professor of anesthesiology and director of the acute pain service, told Medical Xpress that opioids help patients temporarily, but “new-generation stimulators fill an important niche.”
3. Studies have demonstrated SCS devices may prove more impactful for patients who underwent back surgery, but still experience pain.
4. Washington University Pain Management Center physicians see patients at the Center for Advanced Medicine.
More articles on devices:
Medtronic, DePuy Synthes & Stryker lead North American bone grafts & substitutes market — 7 observations
Medtronic announces $2B senior note offering priced: 5 things to know
Reprocessed medical device market to grow by 20% — 5 details
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
